Literature DB >> 17987385

Species comparison of adenosine receptor subtypes in brain and testis.

Gino Giannaccini1, Laura Betti, Lionella Palego, Laura Fabbrini, Lara Schmid, Maura Castagna, Laura Giusti, Giovanni Mascia, Antonio Lucacchini.   

Abstract

We aimed at comparing the binding characteristics of adenosine A(1) and A(2A) receptors (A(1)Rs and A(2A)Rs) in high-expressing cerebral areas, the cortex and striatum respectively, of human, bovine and rat brain. Adenosine A(3) receptor (A(3)R) binding was studied in rat and bovine testis. Results confirmed species differences in AR saturation-displacement binding parameters. To investigate A(3)Rs in CNS, we carried out immunoblot in human brain, resolving two signals, a 52 KDa band with the highest density in hippocampus and a 48 KDa one, slightly more expressed in cortex. Subsequently, A(3)R binding was performed by [(125)I]-4-aminobenzyl-5'-N-methylcarboxamidoadenosine ([(125)I]-AB-MECA) in human hippocampus, revealing an high affinity population of sites and another non saturable component. [(125)I]-AB-MECA first site displacement by N(6 )(3-iodobenzyl)adenosine-5'-N-methyluronamide (IB-MECA) and 1,3-dipropyl-8-cyclopenthyl-xanthine (DPCPX) distinguished two affinity sites, being only in part identified as A(3)Rs. Therefore, A(3)Rs result clearly expressed by Western blot in human brain, but their full CNS characterization needs further investigation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17987385     DOI: 10.1007/s11064-007-9525-4

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  46 in total

Review 1.  The role of receptor structure in determining adenosine receptor activity.

Authors:  M E Olah; G L Stiles
Journal:  Pharmacol Ther       Date:  2000-02       Impact factor: 12.310

Review 2.  The receptor concept: a continuing evolution.

Authors:  Lee E Limbird
Journal:  Mol Interv       Date:  2004-12

3.  Adenosine A2 receptors modulate hippocampal synaptic transmission via a cyclic-AMP-dependent pathway.

Authors:  K Kessey; D J Mogul
Journal:  Neuroscience       Date:  1998-05       Impact factor: 3.590

Review 4.  Adenosine in the central nervous system: release mechanisms and extracellular concentrations.

Authors:  S Latini; F Pedata
Journal:  J Neurochem       Date:  2001-11       Impact factor: 5.372

5.  Excitatory and inhibitory effects of A1 and A2A adenosine receptor activation on the electrically evoked [3H]acetylcholine release from different areas of the rat hippocampus.

Authors:  R A Cunha; E Milusheva; E S Vizi; J A Ribeiro; A M Sebastião
Journal:  J Neurochem       Date:  1994-07       Impact factor: 5.372

6.  Molecular cloning and characterization of the human A3 adenosine receptor.

Authors:  C A Salvatore; M A Jacobson; H E Taylor; J Linden; R G Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

7.  ATP and adenosine inhibit transmitter release at the frog neuromuscular junction through distinct presynaptic receptors.

Authors:  R A Giniatullin; E M Sokolova
Journal:  Br J Pharmacol       Date:  1998-06       Impact factor: 8.739

8.  Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor.

Authors:  Q Y Zhou; C Li; M E Olah; R A Johnson; G L Stiles; O Civelli
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

9.  Rapid stimulation of presynaptic serotonin transport by A(3) adenosine receptors.

Authors:  Chong-Bin Zhu; Jennifer A Steiner; Jaclyn L Munn; Lynette C Daws; William A Hewlett; Randy D Blakely
Journal:  J Pharmacol Exp Ther       Date:  2007-04-25       Impact factor: 4.030

10.  N6-Substituted adenosine derivatives: selectivity, efficacy, and species differences at A3 adenosine receptors.

Authors:  Zhan-Guo Gao; Joshua B Blaustein; Ariel S Gross; Neli Melman; Kenneth A Jacobson
Journal:  Biochem Pharmacol       Date:  2003-05-15       Impact factor: 5.858

View more
  3 in total

1.  Controlling murine and rat chronic pain through A3 adenosine receptor activation.

Authors:  Zhoumou Chen; Kali Janes; Collin Chen; Tim Doyle; Leesa Bryant; Dilip K Tosh; Kenneth A Jacobson; Daniela Salvemini
Journal:  FASEB J       Date:  2012-02-17       Impact factor: 5.191

Review 2.  Identification of A3 adenosine receptor agonists as novel non-narcotic analgesics.

Authors:  K Janes; A M Symons-Liguori; K A Jacobson; D Salvemini
Journal:  Br J Pharmacol       Date:  2016-03-06       Impact factor: 8.739

3.  Treatment of chronic neuropathic pain: purine receptor modulation.

Authors:  Kenneth A Jacobson; Luigino Antonio Giancotti; Filomena Lauro; Fatma Mufti; Daniela Salvemini
Journal:  Pain       Date:  2020-07       Impact factor: 7.926

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.